Cambrex Corp (NYSE:CBM)

51.95
Delayed Data
As of 4:02pm ET
 0.00 / 0.00%
Today’s Change
42.55
Today|||52-Week Range
62.95
+8.23%
Year-to-Date
No recent news for Cambrex Corp.

Today’s Trading

Previous close51.95
Today’s open52.00
Day’s range51.90 - 53.05
Volume150,835
Average volume (3 months)409,024
Market cap$1.7B
Data as of 4:02pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+23.39%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+9.04%
P/E ratio16.8
Price/Sales3.00
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-0.88-3.03%
CORTCorcept Therapeutics...+0.42+2.74%
ARRYArray Biopharma Inc+0.47+2.73%
RGENRepligen Corp+0.64+2.02%
Data as of 4:00pm ET, 02/21/2018

Financials

Last reporting dateFebruary 7, 2018
EPS forecast (this quarter)$1.12
Annual revenue (last year)$535.0M
Annual profit (last year)$102.5M
Net profit margin19.39%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts